Welcome to the redesigned epilepsy.com
It is now easier and faster than ever to access news, articles and community content. With less clutter and an improved navigation system, your favorite content is now only a click away.
The new features include:
Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAYIf you visit PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), a service of the National Library of Medicine, you can read summaries of studies that have tested carbamazepine, as well as other reports about this medication.
Here are links to some articles relevant to this subject:
Mattson, RH, Cramer, JA, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic clonic seizures. New England Journal of Medicine 313:145-151, 1985. PMID: 3925335.
Carbamazepine was more effective than primidone or phenobarbital in controlling partial seizures. Overall, carbamazepine and phenytoin (Dilantin) are the first choices for a single medication to treat adults with newly diagnosed partial seizures, generalized tonic-clonic seizures, or both.
Mattson, RH, Cramer, JA, et al. A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults. New England Journal of Medicine, 327:765-771, 1992. PMID: 1298221.
Carbamazepine and valproate (Depakote) are equally effective for treating generalized tonic-clonic seizures in adults. Although other studies show that valproate is effective for newly diagnosed partial seizures, in this study carbamazepine provided better control of complex partial seizures. The side effects of these two medications are different.
Snead OC III, Hosey LC. Exacerbation of seizures in children by carbamazepine. New England Journal of Medicine 1985;313:916-21.
A call for caution when using carbamazepine in children with mixed seizure disorders.
Read more about how to find and understand information in PubMed.
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.
|
New - Invitation to the Epilepsy Pipeline Conference on March 13
Created by at3/7/08 - 11:31 am|3 Comments |
